Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
W. Strobel, D. Miedinger, J. Leuppi, M. Tamm (Basel, Switzerland). Effect of nasal topical steroids on CPAP compliance in patients with obstructive sleep apnoea starting therapy. Eur Respir J 2007; 30: Suppl. 51, 2769

Member's Comments

No comment yet.

Related content which might interest you: Objective compliance with oral appliance therapy versus CPAP in moderate obstructive sleep apnea Source: International Congress 2017 – CPAP therapy Year: 2017 Effect of heated humidification and topical steroids on compliance, nasal symptoms and quality of life in patients with obstructive sleep apnoea syndrome using nasal continuous positive airway pressure Source: Eur Respir J 2006; 28: Suppl. 50, 412s Year: 2006 Nasal inflammation and compliance with nasal CPAP therapy in obstructive sleep apnoea (OSA) Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health Year: 2012 Efficacy testing for oral appliance therapy in obstructive sleep apnea Source: Virtual Congress 2021 – Advances in therapeutic plans for sleep disordered breathing Year: 2021 Long-term cardiovascular outcomes of patients with obstructive sleep apnoea not treated with nasal CPAP Source: Eur Respir J 2002; 20: Suppl. 38, 294s Year: 2002 Long-term CPAP compliance in women with obstructive sleep apnoea Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health Year: 2012 Role of CPAP treatment in elderly with moderate obstructive sleep apnea Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects Year: 2019 Possibility of treating patients with obstructive sleep apnea syndrome and nocturnal asystoles using CPAP therapy Source: Annual Congress 2009 - Clinical aspects of sleep apnoea Year: 2009 Control of breathing in obstructive sleep apnoea patients: Role of CPAP therapy Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health Year: 2012 Oral devices in the treatment of obstructive sleep apnoea short and long-term treatment Source: Eur Respir J 2003; 22: Suppl. 45, 95s Year: 2003 The influence of long-term CPAP therapy on metabolic variables in obstructive sleep apnea patients Source: International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing Year: 2018 Clinical implications of residual sleep apnoea after chronic CPAP therapy Source: Breathe 2011; 7: 289-290 Year: 2011 Effects of long term nCPAP treatment on patients with obstructive sleep apnoea syndrom Source: Eur Respir J 2007; 30: Suppl. 51, 322s Year: 2007 Effect of treatment with CPAP in patients with resistant hypertension and obstructive apneas Source: Eur Respir J 2005; 26: Suppl. 49, 113s Year: 2005 Efficacy of a FOT-based auto-CPAP device for the treatment of obstructive sleep apnea Source: International Congress 2018 – New diagnostic tools for sleep and breathing and healthcare provision options Year: 2018 The effect of nasal tramazoline with dexamethasone in obstructive sleep apnoea patients Source: Eur Respir J 2013; 42: 1055-1063 Year: 2013 Wrist-actigraphic estimation of sleep time under nCPAP treatment in sleep apnoea patients Source: Eur Respir J 2004; 23: 891-895 Year: 2004 Nasopharyngoscopic evaluation of oral appliance therapy for obstructive sleep apnoea Source: Eur Respir J 2010; 35: 836-842 Year: 2010 CPAP treatment for obstructive sleep apnoea syndrome after CPAP training term Source: Eur Respir J 2002; 20: Suppl. 38, 102s Year: 2002 Cardiovascular regulation effects of CPAP therapy in obstructive sleep apnea patients with and without hypertension during daytime Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA II Year: 2012